BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10570417)

  • 1. Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma.
    Ikeguchi M; Sakatani T; Endo K; Makino M; Kaibara N
    Cancer; 1999 Nov; 86(10):1944-51. PubMed ID: 10570417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized nuclear morphometry: a new morphologic assessment for advanced gastric adenocarcinoma.
    Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Ann Surg; 1999 Jan; 229(1):55-61. PubMed ID: 9923800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
    Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
    J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma.
    Ikeguchi M; Taniguchi T; Makino M; Kaibara N
    Scand J Gastroenterol; 2000 Aug; 35(8):839-46. PubMed ID: 10994623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity.
    Ikeguchi M; Sato N; Hirooka Y; Kaibara N
    J Surg Oncol; 1998 Aug; 68(4):225-30. PubMed ID: 9721707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear accumulation of p53 protein in gastric cancer strongly correlates with enlargement of nuclear area of cancer cells.
    Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Oncol Rep; 2000; 7(3):579-84. PubMed ID: 10767371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nuclear morphometric analysis of colorectal adenocarcinoma and its clinicopathologic significance].
    Yi PY; Yang GH; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 1994; 23(3):141-3. PubMed ID: 7954951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of nuclear morphometry in analysing heterogeneity of grade-II colorectal adenocarcinomas].
    Yi P; Yang G; Tan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Dec; 25(4):449-51. PubMed ID: 7744394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
    Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?
    Betge J; Schneider NI; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Langner C
    J Clin Pathol; 2012 Sep; 65(9):847-50. PubMed ID: 22569541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
    Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2006; 26(1B):455-62. PubMed ID: 16739305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of colorectal cancer prognosis through nuclear morphometry.
    Eynard HG; Soria EA; Cuestas E; Rovasio RA; Eynard AR
    J Surg Res; 2009 Jun; 154(2):345-8. PubMed ID: 18708194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA ploidy pattern of flow cytometry as indicator of degrees of malignancy and prognosis in colorectal cancers].
    Seo K; Yamamura T; Hanai A; Katayama K
    Nihon Rinsho; 1992 Oct; 50(10):2419-25. PubMed ID: 1447812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear morphometry as a prognostic indicator in colorectal carcinoma resected for cure.
    Ambros RA; Pawel BR; Meshcheryakov I; Kotrotsios J; Lambert WC; Trost RC
    Anal Quant Cytol Histol; 1990 Jun; 12(3):172-6. PubMed ID: 2369470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.